Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21990396 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients
Conditions: Multiple Myeloma;   Multiple Myeloma in Relapse
Interventions: Drug: Perifosine;   Drug: Bortezomib;   Drug: Dexamethasone

Indicates status has not been verified in more than two years